This review reports on recent developments in the areas of diagnosis,
chemotherapy and pathology, where female genital schistosomiasis was r
ecently identified as a common cause of morbidity in Schistosoma haema
tobium-endemic areas. As a profound understanding of processes underly
ing resistance and susceptibility to infection as well as pathology is
central to schistosomiasis control, detailed immunological studies of
immunity and granuloma formation dominate the discussion. Studies on
host genetics, on T-helper cell type 1 or 2 cytokines as well as on ce
ll types influencing immunity and granuloma formation have provided pr
ecise information that could be of relevance not only to helminth but
also to microbial infections involving granulomatous reactions. Curr O
pin Infect Dis 11:541-546. (C) 1998 Lippincott Williams & Wilkins.